- Report
- September 2024
- 222 Pages
Global
From €4379EUR$4,950USD£3,729GBP
- Report
- August 2024
- 130 Pages
Global
From €3981EUR$4,500USD£3,390GBP
- Report
- August 2024
- 277 Pages
Global
From €4419EUR$4,995USD£3,763GBP
- Report
- August 2024
- 32 Pages
Global
€15173EUR$17,150USD£12,920GBP
- Report
- July 2024
- 152 Pages
Global
From €3760EUR$4,250USD£3,202GBP
- Report
- July 2024
- 250 Pages
Global
From €4419EUR$4,995USD£3,763GBP
- Report
- June 2024
- 203 Pages
Global
From €4379EUR$4,950USD£3,729GBP
- Report
- June 2024
- 109 Pages
Global
From €2610EUR$2,950USD£2,222GBP
- Report
- January 2025
- 99 Pages
United States
- Report
- June 2025
- 84 Pages
United States
- Report
- May 2025
- 107 Pages
United States
- Report
- August 2024
- 82 Pages
United States
From €1592EUR$1,800USD£1,356GBP
- Report
- January 2025
- 288 Pages
United States
From €4114EUR$4,650USD£3,503GBP
- Report
- November 2024
- 68 Pages
Asia Pacific
From €2875EUR$3,250USD£2,448GBP
- Report
- November 2024
- 78 Pages
Europe
From €2875EUR$3,250USD£2,448GBP
- Report
- December 2024
- 166 Pages
Europe
From €2212EUR$2,500USD£1,883GBP
- Report
- July 2024
- 88 Pages
United States
From €1592EUR$1,800USD£1,356GBP
- Report
- April 2025
- 120 Pages
United States
From €4379EUR$4,950USD£3,729GBP
- Report
- January 2025
- 150 Pages
United States
From €5264EUR$5,950USD£4,482GBP
- Report
- May 2025
- 160 Pages
United States
From €4379EUR$4,950USD£3,729GBP

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more